In the version of this article initially published, on p.231, left-hand column, the maker of linaclotide was said to be Redwood rather than Ironwood Pharmaceuticals. In addition, linaclotide is no longer referred to as a “homolog of the enterotoxin peptides,” but as “similar to the enterotoxin peptides,” and it has been clarified to be “rationally designed.” The errors have been corrected in the HTML and PDF versions of the article.
Additional information
The online version of the original article can be found at 10.1038/nbt.3161
Rights and permissions
About this article
Cite this article
Garber, K. Erratum: Drugging the gut microbiome. Nat Biotechnol 35, 481 (2017). https://doi.org/10.1038/nbt0517-481b
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0517-481b
